Cutera, Inc. (CUTR)
NASDAQ: CUTR · Real-Time Price · USD
0.302
0.00 (-0.13%)
At close: Nov 20, 2024, 4:00 PM
0.306
+0.004 (1.22%)
After-hours: Nov 20, 2024, 6:37 PM EST

Company Description

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide.

It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products.

The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.

It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars.

In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime.

Further, it offers its products through direct sales and services, and network of distributors and direct international sales.

Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

Cutera, Inc.
Cutera logo
Country United States
Founded 1988
IPO Date Mar 31, 2004
Industry Medical Devices
Sector Healthcare
Employees 430
CEO Taylor Harris

Contact Details

Address:
3240 Bayshore Boulevard
Brisbane, California 94005-1021
United States
Phone (415) 657-5500
Website cutera.com

Stock Details

Ticker Symbol CUTR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001162461
CUSIP Number 232109108
ISIN Number US2321091082
Employer ID 77-0492262
SIC Code 3845

Key Executives

Name Position
Taylor C. Harris President, Chief Executive Officer and Director
Stuart D. Drummond Chief Financial Officer
Jeffrey S. Jones Chief Operating Officer
Dr. Stephana E. Patton J.D., Ph.D. Chief Legal Officer
Charles G. Thier Chief Information Officer
Greg Barker Vice President of FP&A and Investor Relations
Steve Kreider Senior Vice President of Global Marketing
Brent Hauser President of International

Latest SEC Filings

Date Type Title
Nov 12, 2024 10-Q Quarterly Report
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 7, 2024 8-K Current Report
Nov 4, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 1, 2024 8-K Current Report
Sep 3, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Aug 9, 2024 10-Q Quarterly Report
Aug 8, 2024 8-K Current Report
Jul 18, 2024 8-K Current Report
Jul 8, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals